Grossberg AJ, Chu LC, Deig CR, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020;70:375–403.

PubMed  PubMed Central  Google Scholar 

Riquelme E, Zhang Y, Zhang L, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795-806.e12.

PubMed  PubMed Central  Google Scholar 

de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374–403.

PubMed  Google Scholar 

Pfeifer E, Burchell JM, Dazzi F, et al. Apoptosis in the pancreatic cancer tumor microenvironment-the double-edged sword of cancer-associated fibroblasts. Cells. 2021;10:1653–70.

PubMed  PubMed Central  Google Scholar 

Hessmann E, Buchholz SM, Demir IE, et al. Microenvironmental determinants of pancreatic cancer. Physiol Rev. 2020;100:1707–51.

PubMed  Google Scholar 

Seton-Rogers S. Fibroblasts shape PDAC architecture. Nat Rev Cancer. 2019;19:418.

PubMed  Google Scholar 

Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat Rev Cancer. 2022;22:131–42.

PubMed  Google Scholar 

Atkinson MA, Campbell-Thompson M, Kusmartseva I, et al. Organisation of the human pancreas in health and in diabetes. Diabetologia. 2020;63:1966–73.

PubMed  PubMed Central  Google Scholar 

Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008;134:981–7.

PubMed  Google Scholar 

Aggarwal G, Kamada P, Chari ST. Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas. 2013;42:198–201.

PubMed  PubMed Central  Google Scholar 

2. Diagnosis and Classification of Diabetes. Standards of Care in Diabetes-2024. Diabetes Care. 2024;47:S20-42.

Google Scholar 

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care. 2003;26(Suppl 1):S5-20.

Google Scholar 

Ewald N, Kaufmann C, Raspe A, et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28:338–42.

PubMed  Google Scholar 

Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(3573–87): e29.

Google Scholar 

Do VH, Canzar S. A generalization of t-SNE and UMAP to single-cell multimodal omics. Genome Biol. 2021;22:130–8.

PubMed  PubMed Central  Google Scholar 

Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12:1088–107.

PubMed  PubMed Central  Google Scholar 

Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7.

PubMed  PubMed Central  Google Scholar 

Wigger L, Barovic M, Brunner AD, et al. Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes. Nat Metab. 2021;3:1017–31.

PubMed  Google Scholar 

Kamarajah SK, Burns WR, Frankel TL, et al. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging system for patients with pancreatic adenocarcinoma: a surveillance, epidemiology and end results (SEER) analysis. Ann Surg Oncol. 2017;24:2023–30.

PubMed  Google Scholar 

Kasurinen J, Hagström J, Kaprio T, et al. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: the additional prognostic value of CD8+-to-CD3+ ratio remains debatable. Tumour Biol. 2022;44:37–52.

PubMed  Google Scholar 

Ackermann Misfeldt A, Costa RH, Gannon M. Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1. Diabetes. 2008;57:3069–77.

PubMed  PubMed Central  Google Scholar 

Kao KC, Vilbois S, Tsai CH, et al. Metabolic communication in the tumour-immune microenvironment. Nat Cell Biol. 2022;24:1574–83.

PubMed  Google Scholar 

Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423–37.

PubMed  PubMed Central  Google Scholar 

Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348:74–80.

PubMed  Google Scholar 

Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309–22.

PubMed  Google Scholar 

Rebelo R, Xavier CPR, Giovannetti E, et al. Fibroblasts in pancreatic cancer: molecular and clinical perspectives. Trends Mol Med. 2023;29:439–53.

PubMed  Google Scholar 

Caronni N, la Terza F, Vittoria FM, et al. IL-1β (+) macrophages fuel pathogenic inflammation in pancreatic cancer. Nature. 2023;623:415–22.

PubMed  Google Scholar 

Wang Y, Ni Q, Sun J, et al. Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer. J Clin Endocrinol Metab. 2020;105:dgz224.

PubMed  Google Scholar 

Javeed N, Sagar G, Dutta SK, et al. Pancreatic cancer-derived exosomes cause paraneoplastic β-cell dysfunction. Clin Cancer Res. 2015;21:1722–33.

PubMed  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.

PubMed  Google Scholar 

Liao WC, Tu YK, Wu MS, et al. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ. 2015;350:g7371–82.

PubMed  PubMed Central  Google Scholar 

Quoc Lam B, Shrivastava SK, Shrivastava A, et al. The Impact of obesity and diabetes mellitus on pancreatic cancer: molecular mechanisms and clinical perspectives. J Cell Mol Med. 2020;24:7706–16.

PubMed  PubMed Central  Google Scholar 

Pizzato M, Turati F, Rosato V, et al. Exploring the link between diabetes and pancreatic cancer. Expert Rev Anticancer Ther. 2019;19:681–7.

PubMed  Google Scholar 

Hart PA, Bellin MD, Andersen DK, et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016;1:226–37.

PubMed  PubMed Central  Google Scholar 

Khadka R, Tian W, Hao X, et al. Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: changes and advances, a review. Int J Surg. 2018;52:342–6.

PubMed  Google Scholar 

Yoon BH, Ang SM, Alabd A, et al. Pancreatic cancer-associated diabetes is clinically distinguishable from conventional diabetes. J Surg Res. 2021;261:215–25.

PubMed  Google Scholar 

Bhattamisra SK, Siang TC, Rong CY, et al. Type-3c diabetes mellitus, diabetes of exocrine pancreas—an update. Curr Diabetes Rev. 2019;15:382–94.

PubMed  Google Scholar 

Andersen DK, Korc M, Petersen GM, et al. Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes. 2017;66:1103–10.

PubMed  PubMed Central  Google Scholar 

Ishida J, Toyama H, Matsumoto I, et al. Glucose tolerance after pancreatectomy: a prospective observational follow-up study of pancreaticoduodenectomy and distal pancreatectomy. J Am Coll Surg. 2021;233:753–62.

PubMed  Google Scholar 

Eizirik DL, Pasquali L, Cnop M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020;16:349–62.

PubMed  Google Scholar 

Rahier J, Guiot Y, Goebbels RM, et al. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab. 2008;10(Suppl 4):32–42.

PubMed  Google Scholar 

Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–10.

PubMed  Google Scholar 

Yoon KH, Ko SH, Cho JH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab. 2003;88:2300–8.

PubMed  Google Scholar 

Salvagno C, Mandula JK, Rodriguez PC, et al. Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity. Trends Cancer. 2022;8:930–43.

PubMed  PubMed Central  Google Scholar 

Goenka A, Khan F, Verma B, et al. Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun (Lond). 2023;43:525–61.

PubMed  Google Scholar 

Marchetti P, del Guerra S, Marselli L, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab. 2004;89:5535–41.